ZSZuhal Önder Siviş

Zuhal Önder Siviş

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zuhal Önder Siviş has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Laboratory-reassuring profiles in pediatric leukemia and lymphoma: a single-center cohort study

    by Mehtap Ertekin, Zühal Önder Siviş, Burcak Tatlı Güneş, Esin Özcan, Salih Gözmen

    Aims: Childhood leukemia and lymphoma may present with overlapping nonspecific symptoms, yet their initial laboratory profiles can differ substantially. Pediatric lymphoma, in particular, may present without cytopenia and with normal lactate dehydrogenase (LDH), potentially creating false reassurance.Methods: We conducted a retrospective single-center cohort study of 81 patients diagnosed with leukemia (n=49; B-ALL 28, T-ALL 7, AML 14) or lymphoma (n=32; NHL 17, Hodgkin lymphoma 15) between January 2024 and January 2026 at a tertiary pediatric hematology–oncology center. Clinical and laboratory findings were compared using Fisher’s exact and Mann–Whitney U tests. The primary analysis compared the prevalence of a laboratory-reassuring profile, defined as simultaneous absence of cytopenia and LDH ≤300 U/L. Results: The laboratory-reassuring profile was present in 16 of 32 lymphoma patients (50%) and in none of the 49 leukemia patients (0%; p

  • Progressive deterioration in dietary intake and nutritional risk during oncological treatment in children with solid tumors: a prospective longitudinal study

    by Ecem Misirlioğlu, Beril Köse, Zuhal Önder Siviş, Eda Ataseven, Derya Hopanci Biçakli, Mehmet Kantar

  • Open Access

    Clinical characteristics, risk factors, and short-term outcomes of pediatric thrombosis in hospitalized non-malignant patients: a single-center study

    by Mehtap Ertekin, Neryal Tahta, Zühal Önder Siviş, Burçak Tatlı Güneş, Esin Özcan, Salih Gözmen

    Aims: Thrombosis in pediatrics differs from that in adults and is mainly provoked. The main triggers include central venous catheterization, critical illness, infection, and immobilization. The factors associated with illness severity and short-term outcome in hospitalized children without cancer remain poorly defined. The aim of this study was to identify such factors and to describe short-term radiological outcomes.Methods: In this retrospective study, hospitalized non-cancer children (≤18 years old) with thrombosis were studied from October 2024 to July 2025. Data on demographics, risk factors, D-dimer levels, thrombophilia testing, treatment modalities, and radiographic responses at 1 and 3 months after diagnosis were collected.Results: Eighty-eight children (median age 2.0 years, IQR 0.0-11.2 years); 58.0% males. All thrombosis episodes occurred in the venous system, and 62.5% were related to the use of catheters. Immobility (48.9%) and sepsis (40.9%) emerged as the predominant risk factors. D-dimer median was 520 ng/ml (IQR 200-1136), with significantly higher levels observed among ICU/palliative care units than in other wards (p

  • Open Access

    Clinical Phenotypes and Glycopeptide Escalation Patterns in Pediatric Febrile Neutro-penia: Associations With Short-Term Outcomes and Acute Kidney Injury Risk

    by Neryal Tahta, Zuhal Onder Sivis, Mehtap Ertekin, Burcak Tatli Gunes, Silem Ozdem Alatas, Esin Ozcan, Salih Gözmen

    Febrile neutropenia (FN) in pediatric oncology is a clinically heterogeneous syndrome in which early antibiotic escalation decisions are frequently driven by nonspecific severity cues. We aimed to identify baseline clinical phenotypes of pediatric FN, to describe early glycopeptide escalation patterns across these phenotypes, and to examine their associations with short-term outcomes and acute kidney injury (AKI). We conducted a retrospective cohort study including 106 FN episodes in 82 pediatric oncology patients initially treated with piperacillin-tazobactam monotherapy. Baseline clinical and laboratory variables available within the first 6 hours of FN onset were used for unsupervised k-means clustering to derive latent clinical phenotypes. Early glycopeptide escalation was defined as initiation of vancomycin or teicoplanin within 48 hours. Associations with day-7 clinical outcomes and AKI were evaluated using cluster-robust multivariable regression and inverse probability of treatment weighting. Three distinct FN phenotypes were identified: a high-inflammatory/mucositis-dominant phenotype (39.6%), a hemodynamically severe phenotype (22.6%), and a lower-severity phenotype (37.7%). Early glycopeptide escalation occurred in 26.4% of episodes and was disproportionately concentrated in the high-inflammatory and hemodynamically severe phenotypes. AKI developed in 10.4% of FN episodes and clustered predominantly within escalation-prone phenotypes. After adjustment, early escalation was not associated with improved day-7 clinical success but was associated with a higher observed risk of AKI. Pediatric FN comprises distinct clinical phenotypes that differentially drive antibiotic escalation behavior and renal injury risk. A phenotype-informed approach may help optimize escalation decisions and potentially reduce preventable toxicity. However, given the observational design, these associations should be interpreted with caution.

  • Open Access

    Evaluation of Patients with Ewing Sarcoma: Single Center Experience

    by Deniz Kızmazoğlu, Zuhal Önder Siviş, Burcak Tatlı Güneş, Esin Özcan, Meral Türker, Berna Atabay, Haldun Öniz

  • What does acute kidney injury and dark red-brown urine that appear after bone marrow transplantation tell us: Answers

    by Demet Alaygut, Gökçen Erfidan, Eren Soyaltın, Zuhal Önder Siviş, Seçil Arslansoyu Çamlar, Fatma Mutlubaş, Belde Kasap Demir

  • Open Access

    Evaluation of Nutritional Anemia in Middle Eastern Immigrant and Refugee Children

    by Dilek Orbatu, Demet Alaygut, Zuhal Önder Siviş, Ahu Pakdemirli, Baris Malbora

    Giriş: Anemi düşük kan hemoglobin konsantrasyonu olarak tanımlanır ve Dünya Sağlık Örgütü (WHO) tarafından küresel anemi prevalansı % 24.8 kadar yüksek bir oranda bildirilmektedir. Günümüzde ise sağlık sistemleri artan mülteci nüfusuyla ve bunların karşılaşacağı sağlık problemleri ile karşı karşıyadır. Bu çalışmanın amacı, göçmen ve mülteci nüfusa hizmet eden hastanemize başvuran çocuk hastalardaki anemi varlığını tesbit etmektir.Yöntem: Çalışma geriye dönük olarak 2012-2018 yıllarını kapsayacak şekilde herhangi bir nedenle Tepecik Eğitim ve Araştırma Hastanesi Çocuk Kliniklerine başvuran 0-18 yaş arası göçmen ve mülteci hastanın değerlendirilmesi yapıldı. Herhangi bir nedenle hastaneye giriş yapan ve hematolojik parametreleri kodlanan hastalar çalışmaya dahil edildi.Bulgular: Toplam 2234 (%46.2) kız olmak üzere 4840 olguya ulaşıldı. Olguların 4793 (%99,0)’ü Suriyeli idi. Ortalama başvuru yaşları 47, 67 ± 57,79 (0-226) ay bulundu. Ortalama Hb değeri 10, 8 ± 1,5, ortalama Hct 32,8 ± 4,3, ortalama MCV 75,9 ± 9,6 ve ortalama RDW 14,9 ± 2,5 saptandı. Ortalama demir değeri 46,41 ± 36,6, demir bağlama kapasitesi (DBK) 379, 52 ± 75,98, transferrin satürasyonu 11,95 ± 9,7 ortalama ferritin değeri ise 94,5 ± 452 olarak hesaplandı. Hb değeri 10 ve altında olan toplam 331 (%6,8), 8 ve altında olan ise 83 ( %1,71) olgu vardı. MCV değeri yaşa göre alt sınırda olan olguların demir eksikliği parametrelerini değerlendirmek amaçlı Menzter, Shine& Lal ve England indeksleri hesaplandı. MCV alt sınırda olup Menzter indeksi >13 olan olgular toplam 1525 idi (714 (%46,8) kız). Bunlarda MCV ile DBK arasında (p= 0,033, korelasyon katsayısı -0,124) ve TS arasında (p= 0,000, korelasyon katsayısı 0,232) anlamlı ilişki vardı. MCV alt sınırda olup Shine > 1530 olan toplam 1934 (886 kız) vardı ve MCV ile hiçbir demir parametresi arasında ilişki bulunmadı. England > 0 olan olguların ise sayısı 1277 idi ve sadece MCV ile TS satürasyonu arasında ilişki bulundu (p= 0,001 ve korelasyon katsayısı 0,223)Tartışma: Her ne kadar çalışmamız geriye dönük olsa ve bir çok veri eksiği içerse de anemi oranını bu popuülasyonda saptamış olması açısından dikkat çekicidir.


  • Hyponatremia in Children with Acute Lymphoblastic Leukemia

    by Deniz Yılmaz Karapınar, Akkız Şahin, Selime Özen, Pınar Yazıcı Özkaya, Zühal Önder Siviş, Ayşe Burcu Akıncı, Nihal Özdemir Karadaş, Bülent Karapınar


  • Retrospective Evaluation of Childhood Cutaneous Mastocytosis Cases

    by Burcu Akıncı, Hamiyet Hekimci Özdemir, Nihal Özdemir Karadaş, Akkız Şahin Yaşar, Zuhal Önder Siviş, Yeşim Aydınok, Kaan Kavaklı, Can Balkan, Deniz Yılmaz Karapınar

  • Open Access

    Fertility in Patients with Thalassemia and Outcome of Pregnancies: a Turkish Experience

    by Burcu Akıncı, Akkız Sahin Yasar, Nihal Özdemir Karadas, Zuhal Önder Sivis, Hamiyet Hekimci Özdemir, Deniz Yılmaz Karapinar, Can Balkan, Kaan Kavakli, Yesim Aydinok

    Objective: In recent years, the rates of marriage and pregnancy are increasing in patients with thalassemia major. The aim of the present study was to investigate the fertility rate of thalassemic patients and the course of pregnancies in terms of mother and infant health. Materials and Methods: In this observational study patients with major hemoglobinopathy were evaluated regarding marital status, the need for assisted reproductive techniques, fertility rate, iron status, and pregnancy complications. Results: Seventeen female patients gave birth to 21 healthy infants. About one-third of the patients needed assisted reproductive techniques. Thalassemia major patients showed increased serum ferritin levels from 1203 +/- 1206 mu g/L. at baseline to 1880 +/- 1174 mu g/L at the end of pregnancy. All babies are still alive and healthy. Conclusion: Pregnancy in patients with thalassemia can be safe for the mother and newborn with close monitoring and a multidisciplinary approach.